Paradromics has received FDA approval to begin human trials for its brain-computer interface, aimed at restoring communication for individuals with…
Read More »neurotechnology
Neurotechnology is rapidly advancing from research to real-world applications, with brain-computer interfaces (BCIs) entering clinical use and attracting significant investment.…
Read More »
Sam Altman is backing Merge Labs, a startup valued at $850 million, to compete with Neuralink in developing brain-computer interfaces,…
Read More »
Sam Altman is reportedly supporting a new brain-computer interface startup, Merge Labs, potentially rivaling Elon Musk’s Neuralink, with OpenAI’s investment…
Read More »